c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. - Wikidata - wikimedia - TriplyDB

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

http://www.wikidata.org/entity/Q42638819

about

In vitro nuclear interactome of the HIV-1 Tat protein SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid Impact of Chromatin on HIV Replication Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus Bromodomain proteins in HIV infection Chromatin, non-coding RNAs, and the expression of HIV Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency G-quadruplexes in pathogens: a common route to virulence control?HIV promoter integration site primarily modulates transcriptional burst size rather than frequency Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation Latency reversal and viral clearance to cure HIV-1.Eradication therapies for HIV Infection: time to begin again."Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.Control of stochastic gene expression by host factors at the HIV promoter.Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence.Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage Combinatorial latency reactivation for HIV-1 subtypes and variants BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 MYC cofactors: molecular switches controlling diverse biological outcomes.Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.Genome-wide analysis of histone modifications in latently HIV-1 infected T cells.Cell line-dependent variability in HIV activation employing DNMT inhibitors Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB A prospective on drug abuse-associated epigenetics and HIV-1 replication.Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.Interaction between endogenous bacterial flora and latent HIV infection.Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.Histone deacetylase inhibitors and HIV latency.Epigenetic heterogeneity in HIV-1 latency establishment.Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.Viral-host interactions that control HIV-1 transcriptional elongation

P2860

Q21245051-4F02F2AE-7413-42D5-A416-187D33A3F655 Q24323711-24849C5B-E3CE-47C5-BCF4-48524B6BF50B Q24596282-113A4F39-03CA-406B-A3FC-C0F18F3278B9 Q26782046-BD4DC856-6604-4DD9-B7D8-DCAF6567D7FE Q26797870-32874DE7-E863-4976-8FB7-BB0AA37B3EDA Q26829860-F8496B7E-D0D5-43F0-BC53-B596CD42AD8C Q27021127-B4A5A3EE-F73F-4508-B6A7-8EBA696BAACA Q27026631-F04F03B6-F3EF-4A88-80CE-83BBBF1254E7 Q28080838-AF4FDEEC-6633-486D-A386-44410ECCB90D Q28475647-17E46975-6622-4893-BCA9-AFFAFDD5E211 Q28537694-575A8C3A-9CFB-4978-A505-E620F7ABB5C8 Q28546901-1FC77876-C566-464D-B8F5-423EC2CD8620 Q30248766-FE3BFEC3-C6BF-4C27-8A44-6C81D8D2DD6F Q30399588-E24E79C3-084B-4840-9A6B-329ED86CBE13 Q30488246-C6E6F565-4F13-4713-A809-2FEE982287AF Q33398516-F420456D-D242-4DF4-B205-E191478EBF50 Q33463283-ACE79F28-2972-434D-A4D8-EF2D4F78A6D6 Q33476165-0DCB825D-2552-438E-B3AD-E5EF0390A910 Q33558251-6C9B62AB-5EB0-477F-A47B-A3C98963BC42 Q33613499-C3902CB9-8302-4FAC-A039-1B958D5B878D Q33724213-6F2E1767-3930-4F92-A857-B0BD3EEE9A5E Q33864438-EF7E73CA-0CDE-4134-8FFA-764C9E659865 Q33877492-55D9F1F1-2C3E-46B6-AB59-B23B0EE071FF Q34032827-8B6C00D8-41AA-4E99-ABFA-D1B835F15ED1 Q34083178-6B57731B-0689-4F3C-9E74-B5499F5B0CE8 Q34090863-CCCBC2B0-5158-4608-9B8C-4E4030E9097F Q34150444-2F9FF57A-551F-4792-A2C2-9FB26E5A0C7E Q34171188-B0EB4C80-53AF-4F3E-8598-4B8939E2CE12 Q34243934-F4FA019F-D5BB-4E01-95A7-A382D5B98BCF Q34249596-0030AC76-8C64-4259-A2B5-09F3AD63CA81 Q34440758-3FD50930-033F-4BC8-A7D1-B1702AEE7B50 Q34482017-BFB7DE8F-483A-4E99-B488-0DAA6591E4A4 Q34612737-276E87DF-DC17-4C0B-96F0-6AE9408A687D Q34671609-657483F6-916E-4A15-8ACB-E6AF3109FC06 Q34686713-8C546917-EA89-4337-B5F5-0EF9CD165D5E Q34741684-F961EBCA-1C88-4174-86E5-82B913276AB6 Q34816844-AE1CE72F-4866-4F51-B4B2-36181FE4FB68 Q34877762-EF3518EA-EC5F-450A-A05D-FF8A2E223D53 Q35016964-EFD3CC44-A16E-454B-80F7-5B6746B37405 Q35026881-E56C9C64-2B9D-42C5-B55E-B53E1914B7D6

P2860

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

http://www.wikidata.org/entity/Q42638819

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@en

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@nl

type

label

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@en

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@nl

prefLabel

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@en

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@nl

P1433

Q42638819-94C0B543-6474-4445-8361-0E3275F3A3EC

P1476

Q42638819-2DBD7D6B-D064-4FB7-9BD6-FA28E2C5AD03

P2093

Q42638819-2945E993-12FE-4714-85C7-31A6A391DDEC

Q42638819-83E56786-C121-4F91-9508-4B8579EC01F5

Q42638819-EB028928-707B-4AC0-90B5-8F161A81EDE1

P2860

Q42638819-02D381FB-9D63-4A05-8D7D-7C90943892E7

Q42638819-052C8363-5093-4414-A87F-4938689340A1

Q42638819-076252D6-76F8-466A-8C00-F407D0A60C79

Q42638819-0ABDFB99-2974-43F9-9C8D-86131CE9089F

Q42638819-0C4AD866-D1F5-4C8C-BBAA-7E37D3AE5BFF

Q42638819-0D8EBFBB-6588-4990-B061-8EAA8BDF00B4

Q42638819-0EDFD3B5-355A-422A-9C69-4E4775D9B4B9

Q42638819-0FC40ADD-8027-4313-878B-2A3A57F98A1D

Q42638819-14E3B02F-AA96-40FF-BA96-3678425713FA

Q42638819-1B7C05AB-8246-4B22-8644-7356080ECCE1

P304

Q42638819-3103C054-EDA5-43B4-B8C0-06BAA7C90E79

P31

Q42638819-6A76AEA9-D559-4300-911C-6AF61817D167

P356

Q42638819-869E2DBE-CD84-4CE1-85D9-D60D1363EEC7

P407

Q42638819-A11DA2E4-5BFB-404F-9104-BCB30EBB75C6

P433

Q42638819-A3781EEE-AF4B-43C1-ABEB-74CA01C2801B

P478

Q42638819-4D242DFB-7C3E-47C1-A668-7B40EA8B95FC

P50

Q42638819-5D81153D-7CB2-4383-9934-8885C3B2A8F3

P577

Q42638819-896EF5E6-3A54-4E45-9E5E-F3F59D65DE6B

P698

Q42638819-E94F26B0-A3A3-44DD-B7E5-2EBA608BABA2

P932

Q42638819-76868796-10CE-4A38-AD2F-E72222D92B9F

P356

P1433

Journal of Virology

P1476

c-Myc and Sp1 contribute to pr ...... iciency virus type 1 promoter.

@en

P2093

Amy Espeseth

http://www.w3.org/2001/XMLSchema#string

Daria J Hazuda

http://www.w3.org/2001/XMLSchema#string

Guochun Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC

Transcriptional repression of human immunodeficiency virus type 1 by AP-4

Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat

Myc represses transcription through recruitment of DNA methyltransferase corepressor

Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter

mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad

Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

Latency: the hidden HIV-1 challenge.

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

P304

10914-10923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01208-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

David M. Margolis

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17670825

http://www.w3.org/2001/XMLSchema#string

P932

2045540

http://www.w3.org/2001/XMLSchema#string